Cost-Effectiveness Analysis of Prognostic Gene Expression Signature-Based Stratification of Early Breast Cancer Patients

BACKGROUND: The individual risk of recurrence in hormone receptor-positive primary breast cancer patients determines whether adjuvant endocrine therapy should be combined with chemotherapy. Clinicopathological parameters and molecular tests such as EndoPredict(®) (EPclin) can support decision making...

Descripción completa

Detalles Bibliográficos
Autores principales: Blank, Patricia R., Filipits, Martin, Dubsky, Peter, Gutzwiller, Florian, Lux, Michael P., Brase, Jan C., Weber, Karsten E., Rudas, Margaretha, Greil, Richard, Loibl, Sibylle, Szucs, Thomas D., Kronenwett, Ralf, Schwenkglenks, Matthias, Gnant, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2014
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4305105/
https://www.ncbi.nlm.nih.gov/pubmed/25404424
http://dx.doi.org/10.1007/s40273-014-0227-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4305105/
https://www.ncbi.nlm.nih.gov/pubmed/25404424
http://dx.doi.org/10.1007/s40273-014-0227-x

Ejemplares similares